Life sciencesAlternativesBeneluxContinental EuropeFranceGermanyInvestmentLondonSouth EastUK & Ireland
9 Jan 2023 13:50 GMT | by May Agaran
Investor interest is growing but lab stock remains very limited in key markets
Want to read the full article?
LSH on board for Northern Trains property mandate
Slate Office REIT internalizing management
Skyline Investments closes sale of 11 US hotels
Colliers buys Ottawa engineering consulting firm
Duo depart PIC following restructure
Empiric nearing £260m postgraduate joint venture agreement
Velocity hurtles towards £30m sale
Investors circle £90m Cambridge landmark that was brought back to life
Barings lets 70,000 sq ft City office to law firm
Mirastar poaches senior Nuveen exec to bolster German team
